{"id":56085,"date":"2023-04-21T13:07:54","date_gmt":"2023-04-21T11:07:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/"},"modified":"2023-04-21T13:07:54","modified_gmt":"2023-04-21T11:07:54","slug":"koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/","title":{"rendered":"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023"},"content":{"rendered":"
\n

MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems (NASDAQ: KRMD) (\u201cKORU Medical\u201d or the \u201cCompany\u201d),<\/b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report first quarter 2023 financial results on Thursday, May 4, 2023. KORU Medical\u2019s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.<\/p>\n

\nConference Call and Webcast Details<\/b><\/p>\n

\nThe conference call can be accessed by dialing (800)-734-8507 for participants in the U.S. or Canada and (212)-231-2925 for international callers, using conference ID: 22026692. A live and archived webcast of the event can be accessed via the IR Calendar on the News\/Events<\/a> page of the Investors section of KORU Medical\u2019s website at www.korumedical.com<\/a>. The archived webcast will be available for six months.<\/p>\n

\nAbout KORU Medical Systems<\/strong><\/p>\n

\nKORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60\u00ae and FreedomEdge\u00ae Syringe Infusion Drivers, Precision Flow Rate Tubing\u2122 and HIgH-Flo Subcutaneous Safety Needle Sets\u2122. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Greg Chodaczek
\n
347-620-7010
\n
investor@korumedical.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems (NASDAQ: KRMD) (\u201cKORU Medical\u201d or the \u201cCompany\u201d), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report first quarter 2023 financial results on Thursday, May 4, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56085","6":"format-standard","7":"category-industry"},"yoast_head":"\nKORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems (NASDAQ: KRMD) (\u201cKORU Medical\u201d or the \u201cCompany\u201d), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report first quarter 2023 financial results on Thursday, May 4, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-21T11:07:54+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023\",\"datePublished\":\"2023-04-21T11:07:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/\"},\"wordCount\":253,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/\",\"name\":\"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-04-21T11:07:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/","og_locale":"en_US","og_type":"article","og_title":"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 - Pharma Trend","og_description":"MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems (NASDAQ: KRMD) (\u201cKORU Medical\u201d or the \u201cCompany\u201d), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report first quarter 2023 financial results on Thursday, May 4, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-21T11:07:54+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023","datePublished":"2023-04-21T11:07:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/"},"wordCount":253,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/","url":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/","name":"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-04-21T11:07:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/koru-medical-systems-to-report-first-quarter-financial-results-on-may-4-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56085"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56085\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}